306 related articles for article (PubMed ID: 7302713)
1. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
2. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
3. Treatment of myasthenia. II.
Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
[No Abstract] [Full Text] [Related]
4. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
5. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
Solé G; Perez F; Ferrer X
Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
[No Abstract] [Full Text] [Related]
6. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
Foldes FF; Smith JC
Ann N Y Acad Sci; 1966 Jan; 135(1):287-301. PubMed ID: 5221345
[No Abstract] [Full Text] [Related]
7. Diseases of the central nervous system. Myasthenia gravis.
Havard CW
Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
[No Abstract] [Full Text] [Related]
8. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
9. [Myasthenia gravis].
Havard CW; Lange MJ
Recenti Prog Med; 1977 Jan; 62(1):9-26. PubMed ID: 323942
[No Abstract] [Full Text] [Related]
10. Myasthenia gravis: a real emergency.
Kutzin JM
Int Emerg Nurs; 2012 Apr; 20(2):102-5. PubMed ID: 22483007
[No Abstract] [Full Text] [Related]
11. Cholinesterase inhibitors in myasthenia gravis.
Lange MJ
Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
[No Abstract] [Full Text] [Related]
12. [Therapetic measures in myasthenia gravis].
Cavaciuti P; Gatti E
Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
[No Abstract] [Full Text] [Related]
13. [On the therapy of muscular diseases].
Mittelbach F; Bodechtel G
Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
[No Abstract] [Full Text] [Related]
14. [Drug therapy in myasthenia gravis].
Aarli JA
Tidsskr Nor Laegeforen; 1976 Dec; 96(34-36):1803-5. PubMed ID: 189451
[No Abstract] [Full Text] [Related]
15. Neostigmine: Not Only for the Operating Room.
Gravino D; McNierney-Moore A
J Emerg Nurs; 2018 Jan; 44(1):94-96. PubMed ID: 29306428
[No Abstract] [Full Text] [Related]
16. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
Tripathi M; Kaushik S; Dubey P
J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
[TBL] [Abstract][Full Text] [Related]
17. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
Lorenzoni PJ; Kay CSK; Ducci RD; Fustes OJH; Werneck LC; Scola RH
Arq Neuropsiquiatr; 2020 Mar; 78(3):179-181. PubMed ID: 32215460
[TBL] [Abstract][Full Text] [Related]
18. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
19. [A curable muscular disease].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1976 Jan; 120(5):181-4. PubMed ID: 1250450
[No Abstract] [Full Text] [Related]
20. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
Riggs JE
Clin Neuropharmacol; 1982; 5(3):277-92. PubMed ID: 6288236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
